113 related articles for article (PubMed ID: 22552867)
1. TLR9 -1237 T/C and TLR2 -194 to -174 del polymorphisms and the risk of Parkinson's disease in the Greek population: a pilot study.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Fidani L
Neurol Sci; 2013 May; 34(5):679-82. PubMed ID: 22552867
[TBL] [Abstract][Full Text] [Related]
2. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.
Mandal RK; George GP; Mittal RD
Mol Biol Rep; 2012 Jul; 39(7):7263-9. PubMed ID: 22311043
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor (TLR)-9 rs352140 Polymorphism is an Immunopathology Protective Factor in Parkinson's Disease in the Northern Iranian Population.
Miri NS; Saadat P; Azadmehr A; Oladnabi M; Daraei A
Iran J Immunol; 2020 Dec; 17(4):313-323. PubMed ID: 33382388
[TBL] [Abstract][Full Text] [Related]
4. Association of TLR9 polymorphisms with sporadic Parkinson's disease in Chinese Han population.
Zhu K; Teng J; Zhao J; Liu H; Xie A
Int J Neurosci; 2016; 126(7):612-6. PubMed ID: 26000920
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.
Li X; Xue L; Sun J; Sun Y; Xie A
Neurosci Lett; 2017 Aug; 656():72-76. PubMed ID: 28729076
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors-2 and -9 (TLR2 and TLR9) gene polymorphism in patients with type 2 diabetes and diabetic foot.
Wifi MA; Assem M; Elsherif RH; El-Azab HA; Saif A
Medicine (Baltimore); 2017 Apr; 96(17):e6760. PubMed ID: 28445304
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Scott RJ
BMC Cancer; 2010 Jul; 10():382. PubMed ID: 20646321
[TBL] [Abstract][Full Text] [Related]
11. Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India.
Srivastava P; Singh A; Kesarwani P; Jaiswal PK; Singh V; Mittal RD
Clin Transplant; 2012; 26(4):581-8. PubMed ID: 22251233
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.
Wujcicka W; Paradowska E; Studzińska M; Wilczyński J; Nowakowska D
Virol J; 2017 Mar; 14(1):64. PubMed ID: 28340580
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
Yang S; Liu L; Xu D; Li X
Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population.
de Oliveira JG; Silva AE
World J Gastroenterol; 2012 Mar; 18(11):1235-42. PubMed ID: 22468087
[TBL] [Abstract][Full Text] [Related]
15. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
Wang F; Tahara T; Arisawa T; Shibata T; Nakamura M; Fujita H; Iwata M; Kamiya Y; Nagasaka M; Takahama K; Watanabe M; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Jun; 22(6):925-9. PubMed ID: 17565650
[TBL] [Abstract][Full Text] [Related]
17. [The correlation between polymorphisms of Toll-like receptor 2 and Toll-like receptor 9 and susceptibility to gastric cancer].
Zeng HM; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Su HJ; Li WQ; Li JY; You WC
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):588-92. PubMed ID: 22041559
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece.
Chatzi M; Papanikolaou J; Makris D; Papathanasiou I; Tsezou A; Karvouniaris M; Zakynthinos E
J Crit Care; 2018 Oct; 47():1-8. PubMed ID: 29860039
[TBL] [Abstract][Full Text] [Related]
19. Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Fidani L
Neurosci Lett; 2013 Apr; 541():190-2. PubMed ID: 23473716
[TBL] [Abstract][Full Text] [Related]
20. Association of Toll-like receptor 9 haplotypes with chronic periodontitis in Czech population.
Holla LI; Vokurka J; Hrdlickova B; Augustin P; Fassmann A
J Clin Periodontol; 2010 Feb; 37(2):152-9. PubMed ID: 20041977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
